JP Morgan Maintains Overweight on Mobia Medical, Raises Price Target to $17

Benzinga Newsdesk www.benzinga.com Positive 82.6%

Neg 0% Neu 0% Pos 82.6%

JP Morgan analyst Robbie Marcus maintains Mobia Medical (NASDAQ:MOBI) with a Overweight and raises the price target from $15 to $17.